Live ticker
Activity
Every trade on Endcap, live. The tape updates in place as new positions clear.
10 trades
- @caseyokaforBoughtYESat 42¢+43 SPon Most-funded GLP-1 weight-loss app of 2026: Sequence (WW)
- @blakeunderhillBoughtNOat 34¢+49 SPon Most-funded GLP-1 weight-loss app of 2026: Found
- @jordanvargasBoughtNOat 43¢+56 SPon First GLP-1 brand to 1M active subscribers: Ro
- @micahbennettBoughtNOat 31¢+45 SPon First GLP-1 brand to 1M active subscribers: Calibrate
- @sashavargasBoughtYESat 62¢+37 SPon First GLP-1 brand to 1M active subscribers: Sequence
- @tatumchenBoughtYESat 40¢+54 SPon Lilly vs Novo: bigger GLP-1 share gain in 2026: Eli Lilly (tirzepatide)
- @haydenlopezBoughtYESat 53¢+30 SPon Generic GLP-1 launch in US: Q3 2026
- @averylopezBoughtNOat 34¢+36 SPon Tirzepatide compounding outcome: Status quo (compounding continues)
- @sashavargasBoughtYESat 83¢+80 SPon First GLP-1 telehealth to raise a mega-round in 2026: Sequence (Weight Watchers)
- @frankieblakeBoughtYESat 59¢+80 SPon First GLP-1 telehealth to raise a mega-round in 2026: Found